Dennis H. Langer Joins Alzheon's Board
This article was originally published in Scrip
Alzheon Inc. has appointed clinical professor Dennis H. Langer to its board of directors. Langer is currently clinical professor in the department of psychiatry at Georgetown University School of Medicine and director of Myriad Genetics Inc., Dicerna Pharmaceuticals Inc. and Delcath Systems Inc. He previously held executive-level positions at GlaxoSmithKline PLC. and its predecessor, SmithKline Beecham, most recently as senior vice president of research and development.